Debt, convertibles, demand.. Most investors currently on

New Post Public Reply Private Reply Replies (2) Message Board
joey68
Debt, convertibles, demand..

Most investors currently on these boards were not involved with SCIE years ago. A lot of information has been lost since then, so lets go back to basics:

The most recent 10K says:


Quote:
Convertible debentures with a face value of $4,313,199 held by 62 investors are in default.


Here's the kicker...Keep reading..
Quote:

None of these investors have served notice of the default of the Convertible debentures


That quote above is the bread and butter of SCIE. This is more than rare. Not one.. not 10.. but all 62 investors have NOT served notice of default. Why? More than likely because they know theyre going to get their money back and then some. Remember, a lot of the investors were personal investors. These people know the company and the people running it. NONE OF THE 62 INVESTORS HAVE SAID, 'GIVE ME BACK MY MONEY'.

and again.. I believe its because they know SCIE is going to be profitable soon. As for the current debt? SCIE was making hundreds of thousands of dollars per QUARTER a few years ago. Any current debt can be paid off rather quickly once sales begin again. Why did sales stop? IM SOUNDING LIKE A BROKEN RECORD!... Because DISTRIBUTION WASNT SET UP YET AND DEMAND WAS TOO MUCH. SCIE is a small medical company and distribution needs to catch up with demand.

Don't believe me?

Read the April 26, 2013 PR:

Quote:
Spectrascience Rescheduling Workshop Due to HIGH DEMAND


SCIE is a classic 'switch of hands' investment. I believe the majority of investors currently invested here wont be around next year because they are in this for the short term. As more and more long term investors come in, the price will naturally increase as shares switch to stronger hands.

Personally, I'm not worried at all about the debt because my DD shows me where the debt came from. If I was not confident in this investment, I wouldn't be wasting my time in an online forum that gets hundreds of views and only a few responses.

Besides.. if investors were to do their DD, theyd know the 10K from 2008 showed debt of $11 MILLION DOLLARS yet get this..

..investors were willing to buy shares at .40 cents, .50 cents and .70 cents PER SHARE. Not only that, but back in 2008, SCIE had NO PROFITABLE OPERATIONS yet. How do I know this? Go DD old online forums and read.

Think about it. This is important. Back in 2009 SCIE had ABSOLUTELY NO HISTORY OF PROFIT yet people were buying shares at 50 CENTS??

These early investors were buying in because they knew way back then that the technology would eventually replace standard biopsies. These early investors had amazing insight.

SCIE has made almost a MILLION dollars in sales in less than 4 years. It could have been more but, as a small company, they didn't set up distribution fast enough.. The product (wavstat) isn't the problem. Management isn't the problem. It's distribution. And SCIE has been perfecting their distribution for the past 2 - 3 years.

As soon as distribution is set (they're almost there), I do believe we will be back in the .20 cent - .50 cent range within the next 5 years or EARLIER. Getting up to .50 cents depends on one major thing happening..

..getting a BIG INVESTOR to invest in SCIE or an acquisition. And if you forgot.. ill post it again..

And don't forget:
Spectrascience is showing on the FRONT webpage for the Medtech conference in 2017 where major INVESTORS match up with promising companies. I'm not making this stuff up. Check it out for yourself:
http://www.ebdgroup.com/mts/index.php


This event in 2017, I believe, is going to propel SCIE to multiple dimes per share. Their logo is on the FRONT page of this website under Johnson & Johnson!

Oh, and I have some great DD ill post tomorrow about acquisitions that have actually occurred..

Not investment advice. I could be totally wrong.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 8

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
Verdafero Gains Ground in Sustainable Hospitality

Updated Category News Views 1

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 1

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

Updated Category News Views 2

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Continue Reading
1M+ California Homes Face Extreme Wildfire Risk Revealed

Updated Category News Views 2

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 2

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 6

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 4

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading

Top 5 Most Recently Viewed Articles

Mowery & Schoenfeld Wealth Awarded Top Advisory Firm by Newsweek

Updated Category News Views 101

Mowery & Schoenfeld Wealth Celebrated as One of America’s Elite Financial Advisory Firms Mowery & Schoenfeld Wealth is thrilled to share the remarkable news of being listed among America’s Top Financial Advisory Firms for 2025 by Newsweek. This honor reflects the firm’s continuous pursuit of excellence in providing personalized financial guidance, groundbreaking...

Continue Reading
Luminar Technologies Reaches New Heights Amid Market Shifts

Updated Category News Views 221

Luminar Technologies Achieves 52-Week High In a market characterized by fluctuations and uncertainty, Luminar Technologies Inc. (NASDAQ: LAZR) has recently announced a significant achievement, touching a 52-week high of $11.39. This milestone is particularly noteworthy for a company that specializes in cutting-edge lidar sensors crucial for the operation of autonomous...

Continue Reading
AKWEL Reports Declining Revenue Over Nine-Month Period

Updated Category News Views 35

AKWEL's Revenue Decline Overview AKWEL, a distinguished manufacturer in the automotive and heavy-vehicle sectors, has recently reported its financial performance for the first nine months of the fiscal year, revealing a notable 5.2% decrease in consolidated revenue compared to the previous period. By the end of September, their revenue totaled €757.7 million, as the...

Continue Reading
Truist Securities Boosts O'Reilly Automotive Target to $1,313

Updated Category News Views 214

Truist Raises Price Target for O'Reilly Automotive Recently, Truist Securities made a notable update on O'Reilly Automotive (NASDAQ: ORLY), revising its price target from $1,290 to an impressive $1,313. This decision, backed by a Buy rating, comes on the heels of the company's robust performance in the third quarter, showing resilience despite the broader challenges faced...

Continue Reading
CGA Expands Team with Cybersecurity Experts for Impactful Insights

Updated Category News Views 304

CGA Expands Team with Cybersecurity Experts In a world where uncertainties loom large, organizations, both public and private, are in constant search of trusted partnerships that can provide clarity on government cyber policy and operations. Cambridge Global Advisors (CGA), a respected service-disabled veteran-owned small business specializing in homeland and national...

Continue Reading